tiprankstipranks
Altimmune Inc (ALT)
NASDAQ:ALT
Holding ALT?
Track your performance easily

Altimmune (ALT) Financial Statements

3,026 Followers

Altimmune Financial Overview

Altimmune's market cap is currently ―. The company's EPS TTM is $-1.554; its P/E ratio is -5.58; Altimmune is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 5.00K$ 5.00K$ 5.00K$ 37.00K$ 362.00K
Gross Profit$ 5.00K$ 5.00K$ 5.00K$ 37.00K$ 362.00K
EBIT$ -22.84M$ -24.64M$ -24.39M$ -31.64M$ -20.64M
EBITDA$ -22.81M$ -23.60M$ -24.29M$ -29.75M$ -20.64M
Net Income Common Stockholders$ -22.84M$ -24.64M$ -24.39M$ -31.64M$ -20.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 139.38M$ 164.91M$ 182.02M$ 197.81M$ 140.78M
Total Assets$ 147.86M$ 173.35M$ 188.36M$ 210.64M$ 166.57M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 4.30M
Net Debt$ -139.38M$ -164.91M$ -182.02M$ -197.81M$ -136.47M
Total Liabilities$ 14.49M$ 15.15M$ 11.33M$ 16.54M$ 16.18M
Stockholders Equity$ 133.38M$ 152.53M$ 172.94M$ 194.10M$ 150.40M
Cash Flow-
Free Cash Flow$ -27.12M$ -18.11M$ -16.36M$ -16.53M$ -20.49M
Operating Cash Flow$ -27.12M$ -18.11M$ -16.36M$ -16.53M$ -20.49M
Investing Cash Flow$ 1.20M$ -3.70M$ -39.52M$ -7.96M$ 4.40M
Financing Cash Flow$ 266.00K$ -46.00K$ -261.00K$ 72.75M$ 588.00K
Currency in USD

Altimmune Earnings and Revenue History

Altimmune Debt to Assets

Altimmune Cash Flow

Altimmune Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis